Implantica AG
Implantica AG engages in the research and distribution of medical implants in Switzerland. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipel… Read more
Implantica AG (IMP-A-SDB) - Total Liabilities
Latest total liabilities as of September 2025: Skr2.75 Million SEK
Based on the latest financial reports, Implantica AG (IMP-A-SDB) has total liabilities worth Skr2.75 Million SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Implantica AG - Total Liabilities Trend (2017–2024)
This chart illustrates how Implantica AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Implantica AG Competitors by Total Liabilities
The table below lists competitors of Implantica AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Tianrui Group Cement Company Limited
F:T18
|
Germany | €20.27 Billion |
|
TVS Electronics Limited
NSE:TVSELECT
|
India | ₹1.84 Billion |
|
Micropolis Holding Company
NYSE MKT:MCRP
|
USA | $40.58 Million |
|
Skillz Platform Inc
NYSE:SKLZ
|
USA | $181.05 Million |
|
Ganesh Benzoplast Limited
NSE:GANESHBE
|
India | ₹1.81 Billion |
|
Eureka Acquisition Corp Class A Ordinary Share
NASDAQ:EURK
|
USA | $1.53 Million |
|
ELK-Desa Resources Bhd
KLSE:5228
|
Malaysia | RM412.26 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Implantica AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 23.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Implantica AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Implantica AG (2017–2024)
The table below shows the annual total liabilities of Implantica AG from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr3.92 Million | -20.06% |
| 2023-12-31 | Skr4.91 Million | +13.54% |
| 2022-12-31 | Skr4.32 Million | +34.41% |
| 2021-12-31 | Skr3.21 Million | +85.46% |
| 2020-12-31 | Skr1.73 Million | -78.73% |
| 2019-12-31 | Skr8.15 Million | +169.73% |
| 2018-12-31 | Skr3.02 Million | +4.31% |
| 2017-12-31 | Skr2.90 Million | -- |